circPIP5K1A accelerated EM progression in vitro by activating the TGF-beta signaling pathway via the miR-153-3p/TMSB4X axis, providing a potential clinical target for EM treatment.
Circular RNA PIP5K1A (circPIP5K1A) accelerates endometriosis progression by regulating the miR-153-3p/Thymosin Beta-4 X-Linked (TMSB4X) pathway.